Company Presentation
NovaGo Therapeutics
| Country: | Swizerland |
| Category: | Emerging Biotech Company |
| Room: | Singapore |
| Date: | 23.04.2024. |
| Time: | 13:00 – 13:15 |
| Website: | https://www.novagotherapeutics.com/ |
| Speaker: | Stefan Moese, CEO |
Company profile
NovaGo Therapeutics is a Swiss biotech company focused on human antibody therapeutics targeting nerve growth and regeneration to enhance functional recovery following spinal cord injury, stroke and diabetic retinopathy. NovaGos therapeutic antibody candidates have shown to enhance nerve repair and functional recovery in preclinical models. Phase 1b clinical trials for the treatment of spinal cord injury are planned to start in 2024.
